Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Inflammatory bone marrow microenvironment

Nils B. Leimkühler, Rebekka K. Schneider

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 294–302.

https://doi.org/10.1182/hematology.2019000045

Published: 2019

Journal Articles

Genetics and prognosis of ALL in children vs adults

Kathryn G. Roberts

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 137–145.

https://doi.org/10.1182/asheducation-2018.1.137

Published: 2018

Journal Articles

Novel approaches to therapy in CML

Ravi Bhatia

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 115–120.

https://doi.org/10.1182/asheducation-2017.1.115

Published: 2017

Journal Articles

Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma

W. Robert Liu, Margaret A. Shipp

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 310–316.

https://doi.org/10.1182/asheducation-2017.1.310

Published: 2017

Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.

https://doi.org/10.1182/asheducation-2015.1.368

Published: 2015

Journal Articles

Do somatic mutations in de novo MDS predict for response to treatment?

Mark A. Schroeder, Amy E. DeZern

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 317–328.

https://doi.org/10.1182/asheducation-2015.1.317

Published: 2015

Journal Articles

BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma

Adrian Wiestner

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 125–134.

https://doi.org/10.1182/asheducation-2014.1.125

Published: 2014

Journal Articles

Hallek M. Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies. Hematology Am Soc Hematol Educ Program. 2013;2013: 138-150 .

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 604.

https://doi.org/10.1182/asheducation-2014.1.604

Published: 2014

Journal Articles

How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?

Edwin Chen, Ann Mullally

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 268–276.

https://doi.org/10.1182/asheducation-2014.1.268

Published: 2014

Journal Articles

Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies

Michael Hallek

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 138–150.

https://doi.org/10.1182/asheducation-2013.1.138

Published: 2013

Journal Articles

Focus on the epigenome in the myeloproliferative neoplasms

Eunhee Kim, Omar Abdel-Wahab

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 538–544.

https://doi.org/10.1182/asheducation-2013.1.538

Published: 2013

Journal Articles

Targeting B-cell receptor signaling: changing the paradigm

Nathan Fowler, Eric Davis

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 553–560.

https://doi.org/10.1182/asheducation-2013.1.553

Published: 2013

Journal Articles

The molecular genetic makeup of acute lymphoblastic leukemia

Charles G. Mullighan

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 389–396.

https://doi.org/10.1182/asheducation.V2012.1.389.3798360

Published: 2012

Journal Articles

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Stefan N. Constantinescu, William Vainchenker

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 553–560.

https://doi.org/10.1182/asheducation.V2012.1.553.3800163

Published: 2012

Journal Articles

Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

Adrian Wiestner

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 88–96.

https://doi.org/10.1182/asheducation.V2012.1.88.3801172

Published: 2012

Journal Articles

Genetic and Epigenetic Complexity in Myeloproliferative Neoplasms

Nicholas C. P. Cross

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 208–214.

https://doi.org/10.1182/asheducation-2011.1.208

Published: 2011

Journal Articles

Using the Biology of Chronic Lymphocytic Leukemia to Choose Treatment

Peter Hillmen

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 104–109.

https://doi.org/10.1182/asheducation-2011.1.104

Published: 2011

Journal Articles

Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia

Jan A. Burger

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 96–103.

https://doi.org/10.1182/asheducation-2011.1.96

Published: 2011

Journal Articles

Pediatric Acute Leukemia Therapies Informed by Molecular Analysis of High-Risk Disease

Stuart S. Winter

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 366–373.

https://doi.org/10.1182/asheducation-2011.1.366

Published: 2011

Journal Articles

Unraveling Mechanisms Regulating Systemic Iron Homeostasis

Karin E. Finberg

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 532–537.

https://doi.org/10.1182/asheducation-2011.1.532

Published: 2011

NARROW

Inflammatory bone marrow microenvironment

Genetics and prognosis of ALL in children vs adults

Novel approaches to therapy in CML

Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma

Prognostic markers and standard management of chronic lymphocytic leukemia

Do somatic mutations in de novo MDS predict for response to treatment?

BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma

Hallek M. Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies. Hematology Am Soc Hematol Educ Program. 2013;2013: 138-150 .

How does JAK2V617F contribute to the pathogenesis of myeloproliferative neoplasms?

Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies

Focus on the epigenome in the myeloproliferative neoplasms

Targeting B-cell receptor signaling: changing the paradigm

The molecular genetic makeup of acute lymphoblastic leukemia

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Emerging role of kinase-targeted strategies in chronic lymphocytic leukemia

Genetic and Epigenetic Complexity in Myeloproliferative Neoplasms

Using the Biology of Chronic Lymphocytic Leukemia to Choose Treatment

Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia

Pediatric Acute Leukemia Therapies Informed by Molecular Analysis of High-Risk Disease

Unraveling Mechanisms Regulating Systemic Iron Homeostasis

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only